Autoimmune diseases occur when the immune system mistakenly attacks healthy tissues. A key driver of this process are B cells, which can drive inflammation and differentiate into plasma cells which produce harmful autoantibodies. These autoantibodies fuel symptoms like muscle weakness in myasthenia gravis or inflammation in lupus.
Telitacicept is an investigational therapy designed to target two signals,BAFF and APRIL, which are known to support B cell survival and activity.
Most therapies for autoimmune diseases focus on easing symptoms or lowering inflammation. While helpful, they often don’t address the underlying immune dysfunction, require continuous use, and primarily target IgG antibodies, even though many diseases also involve IgA and IgM.
As a result, patients may experience incomplete or short-lived improvement.
In conditions like generalized myasthenia gravis and primary Sjögren’s disease, overactive B cells produce harmful antibodies that attack healthy tissues. Two signaling proteins, BAFF and APRIL, fuel this overactivity by helping B cells grow, survive, and produce these autoantibodies.
When BAFF and APRIL are elevated, the immune system can become stuck in a cycle of ongoing B-cell activation and antibody production.
Telitacicept blocks both BAFF and APRIL, helping rebalance B-cell activity at its source. By reducing the survival signals that drive harmful antibody production, it has the potential to:
This approach is being investigated to better understand how targeting upstream pathways may influence disease biology.
By shutting down these signals, telitacicept has the potential to result in:
Unlike broad immunosuppression, telitacicept is being studied for its potential to modulate B cells to reduce harmful inflammation and autoantibody production and restore immune homeostasis at the source.
Generalized myasthenia gravis or gMG is a rare, chronic autoimmune neuromuscular disorder that disrupts communication between nerves and muscles, leading to muscle weakness that can impact mobility, vision, swallowing, and breathing.
Sjögren’s disease is a chronic autoimmune condition in which overactive B cells drive inflammation, damaging moisture-producing glands and, in many cases, other organs. Hallmark symptoms include dry eyes and dry mouth, alongside fatigue, pain, and systemic complications affecting the skin, lungs, kidneys, and nervous system.
